India's First Dengue Vaccine QDENGA Approved! Set for 2025 Launch
India's First Dengue Vaccine QDENGA Approved! Set for 2025 Launch
Big news for public health! India's drug regulator approves QDENGA, the first dengue vaccine, for ages 4-60. Two doses, no prior screening needed. Learn more about this game-changer in disease prevention!
India is on the cusp of a major public health milestone with the recent approval of its first-ever dengue vaccine, QDENGA. The Drug Controller General of India (DCGI) has given the green light to this two-dose vaccine, offering a new ray of hope in the fight against the pervasive mosquito-borne disease. This significant development comes as India grapples with nearly one-third of the global dengue burden.
Manufactured by Takeda, QDENGA has been approved for individuals aged 4 to 60 years. A key advantage of this vaccine is that it can be administered without the need for prior dengue screening, making it more accessible. The vaccination regimen involves two injections of 0.5 ml, given under the skin, three months apart. It's designed to protect against all four serotypes of the dengue virus, which is crucial for comprehensive immunity.
The introduction of QDENGA is particularly timely for India, where rapid urbanisation, changing climate patterns, and widespread mosquito breeding continue to escalate the risk of infection across the country. Dengue, a viral disease reported in over 125 countries, poses a significant public health challenge, leading to hundreds of thousands of cases annually.
Globally, QDENGA has already seen considerable adoption, having been approved in 43 countries with over 32 million doses distributed worldwide. This global track record underscores its potential effectiveness and safety profile. The vaccine is expected to become available in the Indian market as early as next year, promising a new preventive measure for millions.
This approval highlights India's ongoing commitment and role in global vaccine development efforts, bringing a crucial tool to combat a disease that has long plagued communities. While the vaccine offers a powerful new defense, continued efforts in mosquito control and public awareness remain vital in managing the spread of dengue.
